Histone methyltransferase KMT2D promotes castration-resistant prostate cancer progression by reactivating AR through FOXA1

Oncogene 2026

View at publisher
Authors: Mayao Luo, Chenwei Wu, Manli Zhou, Rui Han LIU, Yifan Zhang, Yadong Li, Yuanpeng Liao, Xin Yi Sophie Huang, Chuance Du, Shidong Lv, Qiang Wei
DOI: 10.1038/s41388-026-03828-3
Cited by: 1
References: 49

Fields of Study & Subjects

FOXO transcription factor regulation Prostate Cancer Treatment and Research Histone Deacetylase Inhibitors Research

Publication details

Journal / source
Oncogene
Publisher
Springer Science and Business Media LLC
Volume
45
Issue
26
Pages
2579–2595
Publication date
30 May 2026
Language
EN